World's top Pharmaceuticals stocks
Manufacturers and marketers of generic and specialty drugs, as well as researchers and developers of new drugs, medical products and procedures.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
LLYEli Lilly and Co | $697.40bn | 72.86 | 0.62% |
NOVO BNovo Nordisk A/S | DKK3.91tn | 46.67 | 1.06% |
JNJ WDJohnson & Johnson | $397.54bn | 20.6 | 2.81% |
JNJJohnson & Johnson | $352.17bn | 16.02 | 3.26% |
MRKMerck & Co | $332.33bn | 59.41 | 2.29% |
ABBVAbbvie | $282.63bn | 35.14 | 3.71% |
AZNAstraZeneca | £185.83bn | 47.97 | 1.93% |
ROGRoche Holding AG | CH₣176.19bn | 12.28 | 4.34% |
RORoche Holding AG | CH₣176.19bn | 13.34 | 4% |
NOVNNovartis AG | CH₣175.11bn | 17.14 | 4% |
AMGNAmgen | $144.81bn | 21.12 | 3.16% |
PFEPfizer | $143.83bn | 7.93 | 6.46% |
SANSanofi SA | €114.16bn | 17.27 | 4.12% |
CELG RTBristol-Myers Squibb Co | $90.92bn | 0.01 | 4200% |
BMYBristol-Myers Squibb Co | $90.92bn | 11.96 | 5.15% |
CSLCSL | AU$132.03bn | 33.64 | 1.44% |
GSKGSK | £68.51bn | 11.78 | 3.51% |
GILDGilead Sciences | $81.51bn | 11.73 | 4.62% |
ZTSZoetis | $72.39bn | 30.69 | 0.95% |
MCKMcKesson | $71.39bn | 24.15 | 0.41% |